Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joey L Methot

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Organic Letters|October 24, 2003
Synthetic studies toward FR182877. Remarkable solvent effect in the vinylogous morita-baylis-hillman cyclizationJoey L Methot, William R Roush
Plos One|December 3, 2020
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell functionYun Wang, Kelvin Zhang, Peter Georgiev, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ InhibitorsJoey L Methot, Abdelghani Achab, Matthew Christopher, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2019
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflowXavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2012
Triazoloamides as potent γ-secretase modulators with reduced hERG liabilityChristian Fischer, Susan L Zultanski, Hua Zhou, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2020
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]Xavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Journal of the American Chemical Society|July 12, 2024
High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass SpectrometryXiujuan Wen, Chang Liu, Kiersten Tovar, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2021
Discovery of a new series of PI3K-δ inhibitors from Virtual ScreeningXavier Fradera, Qiaolin Deng, Abdelganhi Achab, et al.
Journal of Medicinal Chemistry|June 23, 2016
Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of CancersJongwon Lim, Elizabeth H Kelley, Joey L Methot, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Organic Letters|October 24, 2003
Synthetic studies toward FR182877. Remarkable solvent effect in the vinylogous morita-baylis-hillman cyclizationJoey L Methot, William R Roush
Plos One|December 3, 2020
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell functionYun Wang, Kelvin Zhang, Peter Georgiev, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ InhibitorsJoey L Methot, Abdelghani Achab, Matthew Christopher, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2019
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflowXavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2012
Triazoloamides as potent γ-secretase modulators with reduced hERG liabilityChristian Fischer, Susan L Zultanski, Hua Zhou, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2020
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]Xavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Journal of the American Chemical Society|July 12, 2024
High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass SpectrometryXiujuan Wen, Chang Liu, Kiersten Tovar, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2021
Discovery of a new series of PI3K-δ inhibitors from Virtual ScreeningXavier Fradera, Qiaolin Deng, Abdelganhi Achab, et al.
Journal of Medicinal Chemistry|June 23, 2016
Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of CancersJongwon Lim, Elizabeth H Kelley, Joey L Methot, et al.
Pageof 3